Skip to content

Rigel Pharmaceuticals RIGL Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$2.41M-0.3%$2.42M-0.1%$2.42M-0.3%$2.43M-0.2%$2.43M+9.2%
$12.84M+1.0%$12.71M+5.5%$12.05M+6.3%$11.33M+7.1%$10.58M-14.6%
$79.27M+4.8%$75.66M+11.0%$68.18M+3.6%$65.83M+85.0%$35.59M+13.1%
$5M0.0%$5M0.0%$5M0.0%$5M0.0%
-$89.79M+2.8%-$92.37M
$0
$20.21M-15.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Rigel Pharmaceuticals generate?
Rigel Pharmaceuticals (RIGL) generated $79.3M in operating cash flow over the trailing twelve months.
Where does Rigel Pharmaceuticals's cash flow data come from?
Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.